Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors?

CTLT’s Segments in Detail Catalent reports via two segments — Biologics and PCH. Revenues in the Biologics segment rose 2.9% year over year on a reported basis (up 3% at CER) to $461 million ...

StockNews.com began coverage on shares of Catalent (NYSE:CTLT – Free Report) in a research report sent to investors on Friday ...

The latest announcement is out from Catalent ( (CTLT) ).

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have been given an average rating of “Hold” by the seven analysts that are presently covering the company, Marketbeat.com reports. Seven analysts ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

A month has gone by since the last earnings report for Catalent (CTLT). Shares have added about 3.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...